Effects of Intermittent Fasting on the Circulating Levels and Circadian Rhythms of Hormones

Abstract

Intermittent fasting has become an increasingly popular strategy in losing weight and associated reduction in obesity-related medical complications. Overwhelming studies support metabolic improvements from intermittent fasting in blood glucose levels, cardiac and brain function, and other health benefits, in addition to weight loss. However, concerns have also been raised on side effects including muscle loss, ketosis, and electrolyte imbalance. Of particular concern, the effect of intermittent fasting on hormonal circadian rhythms has received little attention. Given the known importance of circadian hormonal changes to normal physiology, potential detrimental effects by dysregulation of hormonal changes deserve careful discussions. In this review, we describe the changes in circadian rhythms of hormones caused by intermittent fasting. We covered major hormones commonly pathophysiologically involved in clinical endocrinology, including insulin, thyroid hormones, and glucocorticoids. Given that intermittent fasting could alter both the level and frequency of hormone secretion, decisions on practicing intermittent fasting should take more considerations on potential detrimental consequences versus beneficial effects pertaining to individual health conditions.

INTRODUCTION

Technological breakthroughs have caused dramatic changes in human lifestyle. One typical example is that people can work and eat in the evening and even at night, contrary to the traditional diurnal lifestyle of humans [1]. Cumulative evidence suggests that these lifestyle changes increase the risk of metabolic disorders such as obesity and type 2 diabetes [2].

Intermittent fasting has gained popularity to manage obesity and diabetes. It refers to various diet regimens that involve periodically conducted fasting [3]. This protocol is relatively easy to practice for long periods of time compared to continuous calorie reduction (CR), which requires inconvenient calorie counting every day [4]. One simple approach is alternate-day fasting (ADF), which alternates a day of complete or considerable food restriction with ad libitum food intake for another day. Whole-day fasting (periodic fasting) involves complete or considerable food restriction for 1 to 2 days in a week: for example, the 5:2 diet is to restrict calories by around 75% for 2 days a week. Time-restricted feeding (TRF) allows subjects to eat only for a specific time window during the day. Ramadan fasting, a kind of religious ritual, can be categorized as a type of TRF since meals are consumed only between sunset and dawn during this period.

Beneficial effects of intermittent fasting have been extensively reviewed in recent papers [5–8]. For example, intermittent fasting can improve cognitive and learning abilities in rodents [9,10] and activate antioxidant enzymes and autophagy to resist cellular stress [11,12]. In humans, several studies demonstrate that intermittent fasting decreases body weight, plasma glucose/lipid levels, blood pressure, and inflammation markers [3,13]. On the contrary, other clinical studies showed that intermittent fasting had little effect on weight loss [14,15]. Moreover, it may have potential side effects such as electrolyte imbalance and muscle loss [16,17].

Living animals have biological clocks, called circadian rhythms, which control many aspects of physiological function on a 24-hour cycle. This includes the sleep-wake cycle, blood pressure, heart beat, body temperature and hormonal production/secretion [18,19]. The master clock of systemic circadian rhythms is located in the suprachiasmatic nucleus (SCN) of the hypothalamus, whereas peripheral clocks are distributed in a number of cells throughout the body. The SCN is remarkable in that it is both autonomous and entrained by external time cues. The intra-SCN cellular network endows exceptional robustness to the molecular and neural oscillation of the SCN cellular population, allowing the self-sustainability required to be the master clock [20]. The SCN is also directly innervated by intrinsically photosensitive retinal ganglion cells, enabling it to adjust the circadian phase by utilizing light as a time cue. It then transmits circadian information to peripheral organs through (1) its projection to downstream brain regions, including the paraventricular nucleus of the hypothalamus, dorsomedial hypothalamus, and arcuate nucleus and (2) humoral cues, such as glucocorticoids through its regulation of the hypothalamus-pituitary-adrenal gland (HPA) axis [21].

The autoregulatory feedback loops of transcription–translation serve as the molecular basis of cellular clockworks [20]. Key clockwork transcription factors circadian locomotor output cycles kaput (CLOCK) and brain and muscle Arnt-like protein 1 (BMAL1) form a heterodimeric complex and bind to the promoter of clock genes (period 1–3 and cryptochrome 1/2) to stimulate their production. The protein products of these genes suppress CLOCK/BMAL1, preventing their own transcription [22,23]. Such positive and negative feedback loops generate the cyclic oscillation of clock gene expression over a 24-hour period. This mechanism is found in almost all types of cells, forming the “peripheral clocks” which are regulated by the master clock [21]. Neuroendocrine and endocrine cells are no exception and reportedly harbor functional clockwork, linking the circadian system to hormonal synthesis and secretion.

Recent review papers [3,13,24,25] on intermittent fasting have mainly dealt with changes in anthropometric indices (e.g., body weight, waist circumference, total fat mass), cardiovascular risk factors (e.g., blood pressure, heart beat), metabolite levels (e.g., glucose, cholesterol, triglyceride, ketone bodies), and levels of glucoregulatory hormones (e.g., insulin, leptin, adiponectin). To our knowledge, reviews summarizing changes in hormonal rhythms caused by intermittent fasting are scarce. Therefore, in this review, we will summarize reports on the hormonal alterations caused by intermittent fasting in mammals, especially focusing on their circadian pattern.

EFFECTS OF INTERMITTENT FASTING ON HORMONAL RHYTHMS

As humans and rodents have opposite circadian patterns, research data obtained from human and animal studies must be interpreted with caution. Laboratory rodents are nocturnal and normally fed ad libitum; they consume 90% of foods during the dark cycle and mostly sleep during the light period. In contrast, humans, especially in the period of hunter-gatherers, usually work and eat during the daytime.

In the following paragraphs, we have summarized hormonal changes that have been observed during or after intermittent fasting: the shift in acrophase (the time when hormonal levels reach maximum) and alterations in the amplitude and frequency of daily endocrine rhythms. Moreover, we have described the acute consequences of fasting on various hormones, as studies regarding the effect of intermittent fasting on such hormones are lacking.

Insulin

Insulin is a major metabolic hormone produced in and secreted from pancreatic β cells [26]. In target tissues such as skeletal muscles and adipose tissues, insulin stimulates glucose uptake and storage of excessive energy as glycogen and lipids. Insulin also inhibits glucose production in the liver, thereby lowering postprandial blood sugar to maintain normal blood glucose levels [27].

Interestingly, evidence suggests that insulin production and release in pancreatic β cells is partly regulated by clock proteins. Genetic ablation of clock genes in pancreatic β cells abolished the circadian pattern of insulin secretion and decreased baseline insulin levels below the nadir value of wildtype mice [28,29]. CLOCK and BMAL1 proteins bind to regulatory elements and regulate the expression of genes involved in insulinotropic signals and insulin exocytosis [28,29]. The availability of substrates also plays a part in regulating insulin secretion. Upon rises in blood glucose levels following meal ingestion, pancreatic β cells take in and oxidize glucose to produce adenosine triphosphate (ATP). Elevated ATP closes ATP-dependent inhibitory K⁺ channels, depolarizing the plasma membrane. Subsequently, voltage-dependent Ca²⁺ channels open and extracellular Ca²⁺ enters into the β cells, leading to Ca²⁺-mediated exocytosis of insulin secretory vesicles [30–32]. Consequently, meal-dependent fluctuation of insulin shows an instant postprandial rise and a subsequent decline until the next meal (Figs. 1A, 2A) [33,34]. In laboratory mice, baseline (between meals) plasma insulin levels followed a circadian rhythm with a nocturnal (light-off) peak, which correlated with the diurnal pattern of plasma leptin [35]. In addition to insulin production and secretion, insulin sensitivity also exhibits distinct circadian rhythmicity and partly depends on the local molecular clocks of insulin-sensitive organs [36]. For example, skeletal muscle-specific Bmal1 knockout mice showed impaired insulin-stimulated glucose uptake in skeletal muscle [37]. This study proposed that BMAL1 depletion was associated with decreased levels of glucose transporter type 4 (GLUT4), the insulin-responsive glucose transporter, and the resultant decrease in insulin sensitivity. Another animal experiment revealed that clock proteins, including Rev-Erbα, negatively regulate the expression of the retinol receptor stimulated by retinoic acid 6 (STRA6) in white adipose tissue. STRA6 activation results in decreased insulin sensitivity under normal physiological conditions; therefore, the diurnal variation of STRA6 is one of the molecular mechanisms that mediate the circadian rhythm of insulin sensitivity [38].

Fig. 1.

Graphs illustrating the relative levels of hormones during acute fasting in human (dashed line). Fasting started at different time points (an arrow head in each graph): (A) insulin, fasting onset at 6:00 PM [42], (B) triiodothyronine, fasting onset at 11:30 PM [61], (C) cortisol, fasting onset at 8:30 AM [78]. For comparison, the hormonal level during regular feeding (solid line; breakfast at 7:00 AM, lunch at 12:00 PM, and dinner at 6:00 PM) was depicted in accordance with the clock time. X axis means duration from fasting (hours).

Fig. 2.

Estimated changes in hormones after long-term intermittent fasting in human (dashed line). X axis presents daily light cycle: light box means daytime (6:00 AM–6:00 PM) and dark box indicates nighttime (6:00 PM–6:00 AM). Normal circadian rhythms of hormones were presented with solid line. (A) Insulin; postprandial peaks were depicted after breakfast (7:00 AM), lunch (12:00 PM), and dinner (6:00 PM). (B) Triiodothyronine. (C) Cortisol.

Starvation for 24 hours in mice decreased plasma insulin levels dramatically and abolished the normal circadian rhythm compared with ad libitum mice [35]. Similarly, two ADF studies (3 months and 20 weeks, respectively) in mice reported a dramatic reduction in serum insulin levels by the last week of diet but gave different explanations about this phenotype. In one study [39], total food intake of ADF group mice was less than that of ad libitum group mice, and thus the reduced energy intake was thought to have caused decreased insulin secretion. In the other study [40], total food intake of the ADF group was similar to ad libitum mice because ADF mice consumed twice as much food on fed-days. Therefore, ADF may reduce insulin levels independent of total energy intake, as opposed to CR. On the other hand, the effect of TRF was different from ADF, possibly due to food anticipation. For example, 3 week-TRF in rats (feeding for 8 hours with variable fasting periods) showed a shift in the acrophase (from 9:00 PM to 12:00–1:00 PM) and doubled peak insulin levels compared to ad libitum rats [41].

Likewise, in humans, intermittent fasting decreased plasma insulin levels and improved insulin sensitivity. This change has already been observed during acute fasting. For example, upon 72 hour-fasting, plasma insulin dropped by about 35% during the first 24 hours and reached half of baseline levels by the end of fasting (Fig. 1A) [42]. ADF for 22 days dramatically suppressed insulin secretion by 50% [43]. In studies involving 5:2 diets for 3 or 6 months, blood insulin levels and insulin resistance were significantly reduced. These changes were greater than those induced by CR although the two diets induced comparable weight loss [7,44]. A recent study on 8-week TRF reported similar results [45]. In these human studies, circadian rhythms of insulin levels were not reported. As the consistent reduction in insulin levels induced by intermittent fasting in humans seems to be related to, but not fully explained by, energy restriction, further investigation of its mechanisms, such as changes in pancreatic β cell function or insulin clearance rates, will be needed in the future.

Thyroid hormones

Thyroid hormones (triiodothyronine [T₃] and thyroxine [T₄]) are iodine-containing hormones released from the thyroid gland [46]. Thyroid hormones promote thermogenesis in brown adipose tissue by increasing uncoupling protein expression. In white adipose tissues, thyroid hormones accelerate lipolysis, increasing fatty acids that the liver uses for gluconeogenesis. Thyroid hormones stimulate ATPases in skeletal muscle, which promotes energy expenditure [47].

The hypothalamus-pituitary-thyroid axis (HPT axis) is one of the central pathways regulating energy expenditure: hypothalamic thyrotropin-releasing hormone (TRH) promotes the secretion of thyroid-stimulating hormone (TSH) from the anterior pituitary gland. TSH stimulates the thyroid to release T₄, which is later converted to active T₃ by type I and II deiodinases [48]. The HPT axis is controlled by the SCN through dual mechanisms: hormonal and neural. Tracing by pseudorabies virus in rats showed that SCN neurons project to TRH-expressing neurons in the hypothalamic paraventricular nucleus and directly innervate the thyroid gland [49]. In addition, local clocks in thyrotropes may contribute to the circadian expression of TSH via rhythmic transcriptional repression of REV-ERBα, as suggested by an in vitro study using TαT1.1, a thyrotrope cell line [50]. Under the control of circadian clocks, thyroid hormones peak in the early phase of inactive periods: in nocturnal rodents, TSH peaks at 10:30 AM–12:30 PM and T₃ at 11:00 AM–3:00 PM [51]. Inversely, in humans, TSH level is highest at 2:00–4:00 AM, and T₃ secretion subsequently peaks 1.5 hours after (at 3:30–5:30 AM). The trough of T₃ levels is observed at 5:00–6:00 PM (Figs. 1B, 2B) [52,53].

In rodent experiments, complete fasting for 24 hours lowers serum T₃. This might result from the increased activity of type III deiodinase, which inactivates thyroid hormones [54,55]. Contrary to primary hypothyroidism, in which both TRH and TSH are upregulated as a compensatory response, fasting decreases TRH and TSH levels [56]. This difference could be mediated by alterations of leptin and neuromedin B: restoring leptin concentrations during fasting ameliorated TRH decrease [57] because leptin stimulates hypothalamic TRH neurons via the melanocortin-dependent pathway [58,59]. Meanwhile, pituitary neuromedin B suppresses TSH release, and the proportion of neuromedin B in anterior pituitary proteins increased during fasting [60].

In humans, the T₃ level starts to decrease rapidly after fasting. When measured during 80-hour fasting in healthy subjects, marked T₃ and TSH reductions were observed within 48 hours from fasting onset (Fig. 1B) [61]. Another trial reported that serum T₃ decreased up to 55% after 24 hours of fasting. Contrary to serum T₃, TSH levels remained unchanged after fasting [62]. Short-term (4 weeks) and long-term (more than 6 months) ADF diets reduced circulating T₃ without any change in TSH level [63]. The same result was obtained from another 8-hour TRF (isocaloric, ad libitum within the defined time) study for 8 weeks [64].

Glucocorticoids

Glucocorticoids (corticosterone in rodents and cortisol in humans) are synthesized and secreted by the adrenal cortex. Glucocorticoids stimulate the breakdown of macromolecules and counter-regulate insulin to maintain glucose homeostasis. They also induce anti-inflammatory responses and cardiovascular hypertonicity [65].

The circadian control of blood glucocorticoid levels occurs through multiple mechanisms: hormonal cascade in the HPA cortex axis, autonomic neural signals, and local clocks residing in the adrenal cortex. Neural projections from the SCN to the hypothalamic paraventricular nucleus (PVH) activate the release of corticotropin-releasing hormone (CRH). This stimulates the pituitary to secrete adrenocorticotropic hormone (ACTH), which finally induces glucocorticoid secretion from the adrenal gland [66]. Recent studies have demonstrated a role for PVH neurons including CRH neurons in obesity development via circadian regulation [67,68]. Autonomic nerves from the SCN to the adrenal gland take another part in glucocorticoid release [69,70]. Besides, clock proteins, CLOCK and BMAL1, heterodimerize and bind directly to the promoter of steroidogenic acute regulatory protein (StAR), a rate-limiting component in steroidogenesis, to rhythmically increase its transcription [71]. These mechanisms concertedly drive glucocorticoids to peak at the early activity phase: in rodents, corticosterone peaks at 6:00–6:30 PM when the dark cycle starts [72]. In humans, cortisol reaches acrophase at 7:00–8:00 AM, and gradually declines until midnight (Figs. 1C, 2C) [73,74].

When rats experience 24-hour fasting, the corticosterone peak is delayed by 2 hours. Despite the delay, the peak magnitude remains unchanged [75]. Several TRF studies commonly reported that the peak time of corticosterone moved to the time when feeding started. Food availability only in 8:00 AM–4:00 PM for 2 weeks causes acrophase advance from 8:00 PM to noon in rats [76]. Another TRF trial allowing rats to eat only in 9:00–11:00 AM for 20 days also observed peak shift to 9:00 AM, when feeding started [77].

For humans, cortisol begins to increase immediately after fasting commenced (Fig. 1C) [78]. Five-day fasting increases cortisol levels and shifts the peak from the morning to the afternoon [79]. Other fasting experiments for 2.5 to 6 days dramatically elevates plasma cortisol levels [80–82]. Early TRF (feeding between 8:00 AM–2:00 PM) for 4 days slightly but significantly increases serum cortisol levels in the morning [83]. These results imply that intermittent fasting increases the level and frequency of cortisol secretion.

Miscellaneous

In addition to the aforementioned hormones, changes in other major hormones are covered in this section: growth hormone (GH), estradiol, melatonin, serotonin, and vaspin. However, as reports focusing on the effect of intermittent fasting are extremely limited for these hormones, we choose to briefly enumerate hormonal changes observed mainly in acute fasting.

GH is produced from the anterior pituitary gland and promotes the growth of lean body mass (bone and muscle) and lipolysis [84]. Pituitary GH secretion is mainly controlled by stimulatory growth hormone releasing hormone (GHRH) from the hypothalamus together with ghrelin and inhibitory somatostatin. Like other hormones, the SCN may be involved in the regulation of GH secretion. For example, Npy6r expression, enriched in the SCN, is required to maintain the normal level of GHRH expression from the hypothalamus, although its contribution to the circadian control of the GHRH–GH pathway remains unclear [85]. GH levels naturally peak at sleeping time: rodents at 9:00 AM–12:00 PM [86,87] and humans at 11:00 PM–2:00 AM [88,89]. Fasting for 6 hours in mice or for 72 hours in rats dramatically decreases plasma GH levels, which might be caused by decreased GHRH or increased somatostatin after food deprivation [90,91]. In humans, fasting for 37.5 hours elevates basal GH concentrations by 10-fold and reduces metabolic clearance rate of GH [92]. Other studies reported that the frequency of the GH cycle increased and GH peaks were observed even during daytime after 2- or 5-day fasting [93–95].

The hypothalamus-pituitary-gonad axis (HPG axis) controls the female reproductive cycle, the average period of which is 28 days in humans [96] and 4 days in rodents [97]. A 12-week ADF in rats disrupted the 4-day estrous cycle. Compared with control females, ADF rats show abnormally increased estradiol and significantly decreased luteinizing hormone [98]. Another ADF study in rats for 30 weeks also shows an increased risk of irregular or no estrous cycle [99]. Unlike ADF, 22-week TRF (feeding normal chow only at 9:00 PM–7:00 AM) isocaloric to ad libitum mice shows little effects on estradiol levels and rather improves reproductive function. This study suggests that TRF increases liver fibroblast growth factor 21, which stimulates gonadotropin-releasing hormone (GnRH) secretion from GnRH neurons [100].

Melatonin, derived from tryptophan, is secreted from the pineal gland and synchronizes the body to the central circadian cycle [101]. Melatonin starts to increase at the onset of darkness and peaks at 2:00–4:00 AM [102,103]. In humans, 3-day fasting causes acrophase advance by 81 minutes, but neither the maximal level nor the overall circadian pattern is changed [104]. During Ramadan fasting, the peak of plasma melatonin is lower but its circadian rhythm remains unchanged [105]. These might indicate that melatonin circadian rhythm is mainly regulated by the light/dark cycle rather than the feeding pattern.

Serotonin, as a hormone in blood, is mainly secreted from the enterochromaffin cells and stored in platelets. It exerts pleiotropic effects including vasoconstriction and smooth muscle contraction [106]. Serum serotonin levels exhibit circadian fluctuation: it peaks at 6:00–7:30 AM in humans [107,108] and in the afternoon in rodents [109]. After daytime TRF in rats for 3 weeks, the rhythmic pattern of serotonin in platelet-rich plasma is inversed, that is, the serotonin spikes at dawn instead [110]. Because this is not detected in platelet-free plasma, daytime TRF is thought to influence serotonin uptake and release from platelets.

Vaspin (visceral adipose tissue-derived serine protease inhibitor) attracts attention as an insulin-sensitizing adipokine [111]. Serum vaspin levels rise before meals and falls within 2 hours after eating. Furthermore, the circadian rhythm of vaspin shows a nocturnal rise reaching a peak at 6:00–7:00 AM and a trough at 3:00–4:00 PM in humans [112]. After 20-hour fasting, serum vaspin level is increased in humans [112].

Clinical implications of intermittent fasting

Besides intermittent fasting in healthy subjects, a few studies evaluated its effect on patients with overt or subclinical metabolic diseases. For example, 5-week early TRF (6-hour feeding with dinner before 3:00 PM) was conducted in prediabetic subjects [113]. Although this study did not assess the 24-hour profile of insulin, the TRF regimen improved pancreatic β cell responsiveness to glucose as indicated by oral glucose tolerance test. However, another study testing the effect of 5:2 diet on type 2 diabetic patients over 12 weeks reported that this diet increased the risk of hypoglycemia [114]. Thus, the eligibility of intermittent fasting for diabetic patients should be carefully considered because glucose deprivation and induced ketogenesis can be detrimental to diabetic patients depending on the individual clinical condition [115,116].

A few studies evaluated the effect of intermittent fasting on thyroid abnormalities. In one study, 6-month ADF did not affect either free T₄ or TSH in subclinical hypothyroidism subjects [117]. However, Ramadan studies suggested the need for higher doses of levothyroxine, a globally prescribed drug for hypothyroidism, in primary hypothyroidism patients because their serum TSH levels exceeded normal ranges after the Ramadan fast [118]. Therefore, patients with thyroid abnormalities should consult a physician about the dose and timing of drug intake during intermittent fasting.

Because of very limited research, it is difficult to assess the effect of intermittent fasting on other metabolic diseases such as adrenal insufficiency and Cushing syndrome. However, given the evidence regarding acute hormonal changes occurring immediately after fasting, future studies should further investigate the prolonged effects of intermittent fasting on hormonal status.

CONCLUSIONS

Limited food availability in specific periods stimulates an organism to alter the level and frequency of hormone secretion. To evaluate the efficacy of intermittent fasting, its effect on the endocrine system needs to be thoroughly examined. However, as such studies are scarce, it is difficult to conclude whether intermittent fasting is beneficial in aspect to hormonal changes. Nevertheless, this review aims to cover changes in the circadian rhythm of hormones after intermittent fasting in rodents (Table 1) and humans (Table 2). Furthermore, we organize the findings of several studies on early hormonal changes during acute fasting (Fig. 1) and present an estimate of hormonal changes induced by long-term intermittent fasting (Fig. 2).

Table 1.

Summary on the Changes in Hormonal Circadian Rhythm after Intermittent Fasting in Wildtype Rodents

Hormone	Study	Strain (sex, n)	Type (duration)	Changes after intervention
				Mean level	Acrophase shift
Insulin	Duan et al. (2003) [39]	C57BL/6 mouse (male, 8–10)	ADF (3 months)	↓	ND
	Anson et al. (2003) [40]	C57BL/6 mouse (male, 8)	ADF (20 weeks)	↓	ND
	Rubin et al. (1988) [41]	Sprague-Dawley rat (male, 36 or 48)	TRF (3 weeks)	↑	9:30 PM → 12:00–1:00 PM
Corticosterone	Morimoto et al. (1977) [76]a	Sprague-Dawley rat (female, 4 in each sampling time)	TRF (14 days)	ND	8:00 PM → 12:00 PM
	Wilkinson et al. (1979) [77]	Sprague-Dawley rat (male, 6–8 in each sampling time)	TRF (20 days)	Unchanged	9:00 PM → 9:00 AM

ADF, alternate-day fasting; ND, not determined; TRF, time-restricted feeding.

^aAmong three types of experiments, this review summarized the result obtained from Experiment III.

Table 2.

Summary on the Changes in Hormonal Circadian Rhythm after Intermittent Fasting in Humans

Hormone	Study	Subjects (sex, age, n)	Type (duration)	Changes after intervention
				Mean level	Acrophase shift
Insulin	Heilbronn et al. (2005) [43]	Healthy, nonobese (men, 8; women, 8)	ADF (22 days)	↓	ND
	Harvie et al. (2011) [7]	Overweight or obese (women, 42)	5:2 diet (6 months)	↓	ND
	Harvie et al. (2013) [44]	Overweight (women, 37)	5:2 diet (4 monthsa)	↓	ND
	Cienfuegos et al. (2020) [45]	Obese (4 hours TRF: 16, 6 hours TRF: 19)	TRF (8 weeks)	↓	ND
Triiodothyronine	Stekovic et al. (2019) [63]	Healthy (4 weeks: 29, 6 months: 30)	ADF (4 weeks, 6 months)	↓	ND
	Moro et al. (2016) [64]	Resistance-trained (men, 17)	TRF (8 weeks)	↓	ND
Cortisol	Jamshed et al. (2019) [83]	Overweight (men, 7; women, 4)	TRF (4 days)	↑	ND

ADF, alternate-day fasting; ND, not determined; TRF, time-restricted feeding.

^aWeight-loss period for 3 months and weight-stabilizing period for 1 month.

In studying hormonal circadian rhythms, it is the interval between blood sampling that determines the accuracy and confidence of the experiments. In view of this, studies in rodents have an intrinsic limitation since frequent blood sampling is not feasible due to the small volume of total blood. On the other hand, research in human subjects can utilize blood samples collected at minute intervals, but usually the study pool is very small.

To clarify the effects and mechanisms of intermittent fasting and to examine whether we can recommend intermittent fasting regimes to patients with various metabolic diseases, further research needs to be conducted taking several factors into consideration. First, the analysis should discern the effect of intermittent fasting from that of reduced calorie intake, as calorie restriction itself has clinical implications. Reduced energy intake in certain types of intermittent fasting should be distinguished from isocaloric energy intake in TRF when analyzing the impact of intermittent feeding. Second, it seems that the coordination between feeding time and activity period of the organism is important, suggesting actimetry along with hormonal measurement as the gold standard in future research. In this point of view, it will be useful to study the results of dysregulated coordination between eating and activity patterns (i.e., night eating syndrome in humans). Third, the observed data should be translated with care to embrace possible interactions among hormonal systems as well as circadian fluctuations in the susceptibility of target organs. We speculate that well-designed studies will establish a better understanding of intermittent fasting and its effects on circadian hormonal regulation. This will enable the development of an efficient and safe intermittent fasting protocol with improved circadian hygiene.